Our advanced Sirolimus Coated Balloons and Sirolimus Eluting Stents are designed to treat Coronary Artery Disease and Peripheral Artery Disease with precision and safety.
nanolute
DCB Product Family
Transformation of Sirolimus medication to sub-micron-sized particles encapsulated in biocompatible phospholipid nanocarriers, reducing systemic exposure and supporting shorter dual antiplatelet therapy (DAPT) for improved patient outcome.

TECHNOLOGY PLATFORMS
ENVISOLUTION
DES Product Family
Integration of target-specific coating for precise drug delivery, where Abluminus, a polymer-free sirolimus-eluting stent tailored for diabetes patients, promotes rapid re-endothelialization and reduces systemic exposure.